The RAGE of COPD
慢性阻塞性肺病的愤怒
基本信息
- 批准号:8669718
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdvanced Glycosylation End ProductsAlveolarAlveolar MacrophagesAnimal ModelApoptosisBiochemicalCause of DeathCellsChronicChronic Obstructive Airway DiseaseCigarette SmokerComplementDataDevelopmentDiagnosisDiseaseEpithelial CellsEpithelial Receptor CellExposure toFamilyGenerationsGeneticHMGB1 ProteinHospitalsInflammationInflammatoryInflammatory ResponseLeadLeukocyte L1 Antigen ComplexLigandsLungLung InflammationLung diseasesMediatingMedicalModelingMononuclearMusMutant Strains MiceNADPH OxidaseOutcomePathogenesisPathway interactionsPeptide HydrolasesPublicationsPulmonary EmphysemaReactive Oxygen SpeciesReceptor InhibitionRelative (related person)Research DesignRoleSignal PathwaySignal TransductionSourceStressTestingValidationabstractingalveolar epitheliumbasecigarette smokingcigarette smokingclinical applicationcytokinemacrophagemembermouse modelnovel strategiesoxidant stresspreventpublic health relevancereceptorreceptor expressiontranscription factor
项目摘要
DESCRIPTION (provided by applicant):
Abstract: Objective: To determine the pathogenic mechanisms of COPD and to define new ways to prevent or treat the disorder. Hypotheses: We propose a new paradigm for a central role of the receptor for advanced glycation end products (RAGE) and its ligands in the emphysema pathogenesis. We hypothesize that RAGE and its ligands through distinct signaling pathways that include NADPH oxidase(s) (Nox)-generated reactive oxygen species (ROS) activate key transcription factors including NF-B and EGR-1 to propagate the inflammation, apoptosis and lung destruction leading to emphysema. Background: Chronic obstructive pulmonary disease (COPD) is a devastating disorder characterized by chronic airflow limitation. It is among the most common discharge diagnoses from VA hospitals and will be the third leading cause of death worldwide by the year 2020. In part, due to the still poorly elucidated or undiscovered mechanisms causing COPD, treatment options are very limited. COPD is associated with chronic inflammation, apoptosis and emphysema. This proposal is aimed at defining the biochemical mechanisms for the inflammation, apoptosis and emphysema. Aims: Aim 1 will determine the ability of RAGE and its ligands to promote inflammation, apoptosis and lung destruction leading to the development of emphysema. It will test the hypothesis that advanced glycation end products (AGEs) or other ligands interact with RAGE to amplify the inflammatory response and apoptosis that mediate the lung destruction leading to the development of emphysema. Aim 2 will determine the role of signaling intermediates in RAGE-induced lung inflammation, apoptosis and destruction leading to the development of emphysema. It will test the hypothesis that RAGE and its ligands acting through Nox(s) and NF-B or Egr-1, cause synthesis and release of pro-inflammatory cytokines and additional RAGE ligands, which further perpetuate RAGE expression, inflammation, oxidative and/or proteinase stress and apoptosis with resulting lung destruction. Aim 3 will determine whether lung macrophage RAGE or alveolar epithelial cell RAGE is primarily responsible for propagating inflammation, apoptosis and lung destruction leading to the development of emphysema. These studies will take advantage of unique mouse models with mononuclear or alveolar epithelial cell specific deletion of RAGE to test the hypothesis that lung macrophage RAGE is the primary effector of RAGE-mediated inflammation and lung destruction. Research Design: We will study the expression of RAGE and its ligands during the development of emphysema using a model of cigarette smoke exposure to mice. Mutant mice exposed to cigarette smoke will be used to determine the importance of RAGE and specific signaling pathways in emphysema development. Studies in isolated cells exposed to cigarette smoke extract will complement those proposed in mouse models to aide in delineating signaling pathways. A particular focus will be the role(s) of RAGE expressed on lung macrophages and alveolar epithelium since these are the primary sources of RAGE expression in the lungs of cigarette smokers. Significance: Successful outcome of this proposal will transform basic understanding of the pathobiochemistry of emphysema by focusing on pathways currently only tangentially mentioned in discussions of the mechanisms for development of the disorder. It will impact our ability to prevent or reduce the enormous medical burden caused by cigarette smoking. Nowhere is the need for new approaches with clinical application more important in pulmonary diseases than in COPD.
描述(由申请人提供):
【摘要】:目的:明确慢性阻塞性肺病(COPD)的发病机制,并寻找预防或治疗该疾病的新方法。假设:我们提出了晚期糖基化终末产物受体(RAGE)及其配体在肺气肿发病机制中的核心作用的新范例。我们假设 RAGE 及其配体通过不同的信号传导途径,包括 NADPH 氧化酶 (Nox) 产生的活性氧 (ROS) 激活关键转录因子,包括 NF-B 和 EGR-1,从而传播炎症、细胞凋亡和肺部破坏,导致肺气肿。背景:慢性阻塞性肺疾病(COPD)是一种以慢性气流受限为特征的破坏性疾病。它是退伍军人管理局医院最常见的出院诊断之一,到 2020 年将成为全球第三大死亡原因。部分原因是慢性阻塞性肺病的致病机制尚未阐明或尚未发现,治疗选择非常有限。 COPD 与慢性炎症、细胞凋亡和肺气肿有关。该提案旨在明确炎症、细胞凋亡和肺气肿的生化机制。目标:目标 1 将确定 RAGE 及其配体促进炎症、细胞凋亡和肺部破坏从而导致肺气肿发展的能力。它将检验以下假设:晚期糖基化终末产物 (AGE) 或其他配体与 RAGE 相互作用,放大炎症反应和细胞凋亡,介导肺部破坏,导致肺气肿的发展。目标 2 将确定信号中间体在 RAGE 诱导的肺部炎症、细胞凋亡和破坏(导致肺气肿发展)中的作用。它将检验以下假设:RAGE 及其配体通过 Nox 和 NF-B 或 Egr-1 起作用,导致促炎细胞因子和其他 RAGE 配体的合成和释放,从而进一步维持 RAGE 表达、炎症、氧化和/或蛋白酶应激和细胞凋亡,从而导致肺破坏。目标 3 将确定肺巨噬细胞 RAGE 或肺泡上皮细胞 RAGE 是否主要负责传播炎症、细胞凋亡和肺部破坏,从而导致肺气肿的发展。这些研究将利用单核或肺泡上皮细胞特异性删除 RAGE 的独特小鼠模型来检验肺巨噬细胞 RAGE 是 RAGE 介导的炎症和肺部破坏的主要效应器的假设。研究设计:我们将使用小鼠吸烟模型来研究肺气肿发展过程中 RAGE 及其配体的表达。暴露于香烟烟雾的突变小鼠将被用来确定 RAGE 和特定信号通路在肺气肿发展中的重要性。对暴露于香烟烟雾提取物的分离细胞进行的研究将补充小鼠模型中提出的研究,以帮助描绘信号通路。特别关注的是肺巨噬细胞和肺泡上皮表达的 RAGE 的作用,因为这些是吸烟者肺部 RAGE 表达的主要来源。意义:该提案的成功结果将通过关注目前在疾病发展机制的讨论中仅间接提及的途径,将改变对肺气肿病理生物化学的基本理解。它将影响我们预防或减轻吸烟造成的巨大医疗负担的能力。在肺部疾病中,没有什么比慢性阻塞性肺病更需要临床应用的新方法了。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John R Hoidal其他文献
Chronic Endurance Stress Induces Cardiac Remodeling in Aged Nrf2-Null Mice
- DOI:
10.1016/j.freeradbiomed.2012.10.433 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Dinesh Devadoss;Sellamuthu S. Gounder;Sankaranarayanan Kannan;Naqser Abu-Rmaileh;Kevin S Whitehead;E. Dale Abel;John R Hoidal;Rajasekaran Namakkal-Soorappan - 通讯作者:
Rajasekaran Namakkal-Soorappan
PSS252 - Ablation of Nrf2 Sensitizes Skeletal Muscle to Cardiotoxin Induced Oxidative Stress and Impairs Regeneration
- DOI:
10.1016/j.freeradbiomed.2013.10.675 - 发表时间:
2013-11-01 - 期刊:
- 影响因子:
- 作者:
Naser Abu-Rmaileh;Sankarnarayanan Kannan;Jennifer Hong;Nancy Atieno;Christopher J Davidson;Russell Richardson;Aldrin V Gomes;John R Hoidal;Rajasekaran Namakkal Soorappan - 通讯作者:
Rajasekaran Namakkal Soorappan
Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective
- DOI:
10.1007/s11912-020-00992-x - 发表时间:
2021-01-01 - 期刊:
- 影响因子:5.000
- 作者:
Tapan K Mukherjee;Parth Malik;John R Hoidal - 通讯作者:
John R Hoidal
PSS264 - Nrf2 Deficiency Promotes Apoptosis and Impairs Pax7/MyoD Lineage in Aging Skeletal Muscle
- DOI:
10.1016/j.freeradbiomed.2013.10.687 - 发表时间:
2013-11-01 - 期刊:
- 影响因子:
- 作者:
Sankarnarayanan Kannan;Christopher J Davidson;Naser Abu-Rmaileh;Russell Richardson;Aldrin V Gomes;John R Hoidal;Rajasekaran Namakkal Soorappan - 通讯作者:
Rajasekaran Namakkal Soorappan
John R Hoidal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John R Hoidal', 18)}}的其他基金
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
- 批准号:
6796754 - 财政年份:2002
- 资助金额:
-- - 项目类别:
Nicotine Abuse /Smoking-Related Disease Susceptibility
尼古丁滥用/吸烟相关疾病的易感性
- 批准号:
6549070 - 财政年份:2002
- 资助金额:
-- - 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
- 批准号:
6471692 - 财政年份:2002
- 资助金额:
-- - 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
- 批准号:
7098903 - 财政年份:2002
- 资助金额:
-- - 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
- 批准号:
6631428 - 财政年份:2002
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




